CCAM
CORZ icon

Capelight Capital Asset Management’s Core Scientific CORZ Stock Holding History

Capelight Capital Asset Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2M Buy
750,000
+150,000
+25% +$3.53M 9.21% 2
2026
Q1 		$8.98M Buy
600,000
+555,000
+1,233% +$9.47M 6.7% 2
2025
Q4 		$655K Buy
+45,000
New +$785K 0.52% 34

Other funds holding CORZ

OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Capelight Capital Asset Management's CORZ Position: Q2 2026 in Review

Capelight Capital Asset Management increased its Core Scientific (CORZ) stake by 25% in Q2 2026, buying an estimated $3.53M and bringing the position to 750,000 shares worth $19.2M. The position accounts for 9.21% of the portfolio, ranked #2.

Capelight Capital Asset Management first reported a position in CORZ in Q4 2025 and has held it in 3 quarters since. 138 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Capelight Capital Asset Management held 750,000 shares of Core Scientific worth $19.2M as of Q2 2026.
  • Capelight Capital Asset Management bought 150,000 Core Scientific shares in Q2 2026, an estimated $3.53M.
  • Core Scientific made up 9.21% of Capelight Capital Asset Management's portfolio in Q2 2026, its #2 holding.
  • Capelight Capital Asset Management first reported a position in Core Scientific in Q4 2025 and has held it in 3 quarters since.
  • 138 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Capelight Capital Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.